Abstract
New series of quinazoline containing sulfonamide derivatives were prepared and screened for their antitumor activity. Four human cancer cell lines, namely, hepatoma cancer cell line (HepG2), breast cancer cell line (MCF-7), cervix cancer cell line (HeLa) and colon cancer cell line (HCT-8), were used to measure the cytotoxic activity. Compounds 8 and 21 exhibited remarkable antitumor activity almost similar to that of the standard drug (doxorubicin). Six compounds 16, 22, 23, 29, 30 and 33, showed considerable activity and few compounds were totally inactive.
| Original language | English |
|---|---|
| Pages (from-to) | 375-383 |
| Number of pages | 9 |
| Journal | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Volume | 28 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antitumor
- Quinazoline
- Sulfonamide
- Synthesis
Fingerprint
Dive into the research topics of 'Quinazoline-sulfonamides as potential antitumor agents: Synthesis and biological testing'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver